Global GPCR Screening Service Market Strategic Research Report

Scope of the Report

The global GPCR Screening Service market size is predicted to grow from US$ 377 million in 2025 to US$ 621 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

GPCR screening services are professional in vitro pharmacological testing services for drug discovery and early-stage research and development. Focusing on G protein-coupled receptor targets, these services help clients discover, confirm, and optimize candidate molecules acting on GPCR targets through cell line construction, receptor expression verification, binding experiments, functional experiments, signal pathway detection, initial compound screening, dose-response confirmation, selectivity evaluation, off-target safety spectral screening, and biased signal analysis.

From a demand structure perspective, targets related to metabolic diseases, obesity, diabetes, neurological diseases, pain, cardiovascular diseases, immune inflammation, and the tumor microenvironment are significant sources of demand for GPCR screening services. The continued development of GLP-1R, GIPR, GCGR, 5-HT receptors, opioid receptors, chemokine receptors, adenosine receptors, S1P receptors, cannabinoid receptors, and orphan GPCRs is driving pharmaceutical and biotechnology companies to conduct receptor function screening, selective profiling, and off-target safety evaluation. With advancements in structural biology, cryo-electron microscopy, AI-assisted molecular design, and allosteric modulator development, customer demand for GPCR services is shifting from "single activity screening" to a combination of services encompassing "multiple pathways, multiple readings, multiple species, and mechanism interpretation." Service providers with orthogonal assay design capabilities are more likely to secure high-value projects.

This report presents a comprehensive overview of the global GPCR Screening Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Gs Pathway Screening
• Gi/o Pathway Screening
• Gq Pathway Screening
• G12/13 Pathway Screening

Segment by Detection Technology

• cAMP Detection
• Calcium Flow Detection
• IP1 Detection

Segment by Number of Compounds Screened Per Session

• <1,000
• 1,000～10,000
• 10,000～100,000
• >100,000

Segment by Application

• Pharmaceuticals
• Disease Treatment
• Research
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global GPCR Screening Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceuticals, Disease Treatment, Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact